Drugs & Stroke: Rising Risk in Young Adults – Cocaine, Meth & Cannabis Link

The perception of stroke as a disease of aging is undergoing a significant shift. For years, hypertension, diabetes, and atrial fibrillation have been the primary risk factors associated with stroke. However, a growing body of evidence reveals that illicit drug use, even in younger adults, can dramatically increase the risk of this life-threatening medical event. A recent, comprehensive analysis from the University of Cambridge underscores this connection, identifying cocaine, amphetamines, and even cannabis as causal risk factors for stroke.

Researchers, led by Dr. Megan Ritson of the Stroke Research Group at the University of Cambridge, published a meta-analysis demonstrating a clear link between recreational drug use and increased stroke incidence. The study, described as the most comprehensive of its kind to date, found that amphetamines and cocaine tripled stroke risk in individuals under the age of 55. Perhaps surprisingly, cannabis use was also associated with a notable increase in risk – a 37 percent elevation, according to the findings. Cambridge University News reports on the study’s implications.

How Drugs Impact Stroke Risk

The mechanisms by which these drugs contribute to stroke are complex and varied. Stimulants like cocaine and methamphetamine have long been known to cause acute cardiovascular complications, but their impact on the brain’s blood vessels is now receiving increased attention. Cocaine, for example, elevates stroke risk by 96 percent, while amphetamines increase it by 122 percent. These substances can destabilize cerebral circulation within minutes, meaning a stroke can occur rapidly following drug use. This is particularly concerning for younger adults who may not have pre-existing vascular risk factors.

Several pathways are believed to be involved. Drug abuse can cause sudden spikes in blood pressure, blood vessel spasm and constriction, heart rhythm problems, and inflammation or vasculitis – all well-established contributors to both ischemic strokes (caused by blood clots) and hemorrhagic strokes (caused by bleeding in the brain). The Cambridge Biomedical Research Centre provides further details on the research.

Stimulants and Cerebral Injury

Methamphetamine and amphetamine abuse are strongly correlated with increased stroke risk. Unlike traditional vascular risk factors that develop over decades, stimulant-related cerebrovascular injury can occur abruptly, even in individuals with no history of hypertension, diabetes, or other common stroke risk factors. These drugs dramatically increase the release of dopamine and norepinephrine, leading to tachycardia (rapid heart rate), systemic vasoconstriction (narrowing of blood vessels), and profound elevations in blood pressure. Acute hypertensive crises can rupture small blood vessels in the brain or preexisting aneurysms, leading to intracerebral or subarachnoid hemorrhage.

stimulant exposure can lead to reversible cerebral vasoconstriction syndrome, a condition characterized by transient narrowing of cerebral arteries and recurrent severe headaches. Chronic methamphetamine exposure is also associated with endothelial injury (damage to the lining of blood vessels) and inflammatory vascular damage, potentially leading to chronic hypertension and progressive vascular injury.

Cocaine’s Impact on the Cardiovascular System

Numerous studies have demonstrated increased risks of both ischemic and hemorrhagic stroke among cocaine users. Cocaine, like methamphetamine, produces potent sympathetic stimulation, resulting in marked elevations in heart rate and blood pressure. These acute hypertensive surges increase the risk of intracerebral hemorrhage and subarachnoid hemorrhage. Cocaine is also a powerful vasoconstrictor, leading to pronounced cardiac and cerebral vasospasm. It increases platelet activation and aggregation, promoting a prothrombotic state that can facilitate arterial thrombosis and contribute to ischemic stroke.

Chronic cocaine use may also accelerate atherosclerosis, the buildup of plaque in the arteries. While many cocaine-associated strokes occur in individuals without established vascular disease, repeated exposure may contribute to premature atherosclerotic changes. Because cocaine-associated strokes frequently occur in young people without conventional vascular risk factors, clinicians should consider cocaine exposure when evaluating unexplained stroke in this population.

Cannabis and the Emerging Risk

Historically considered less harmful than stimulants, cannabis is now being recognized as a potential contributor to cerebrovascular risk. While the association between cannabis and stroke is weaker than that of cocaine or methamphetamine, numerous observational studies have identified a relationship between cannabis exposure and subsequent cerebrovascular events. Epidemiologic analyses have reported increased stroke risk among younger cannabis users, particularly with frequent or recent use. Get Smart About Drugs highlights the findings of the research.

Cannabis exposure has also been associated with reversible cerebral vasoconstriction syndrome, suggesting that transient arterial narrowing may play a role in ischemic events. Cannabis affects autonomic balance, increasing sympathetic activity while reducing parasympathetic tone, which can influence vascular tone and cerebral blood flow regulation. Fluctuations in blood pressure, as well as potential effects on platelet activation and cardiac arrhythmias, may also contribute to stroke risk. Emerging studies suggest cannabis use may be associated with increased risk of myocardial infarction, heart failure, and cardiovascular mortality in younger adults.

What Does This Mean for Public Health?

The National Institutes of Health reports that drug use is a major driver of “unexplained” neurological emergencies, like seizures and strokes, estimating that users aged 15–44 are 6.5 times more likely to suffer a stroke than nonusers. Today, drug abuse is the most common predisposing condition for stroke in patients under age 35. Stroke is a medical emergency requiring rapid recognition and treatment, as even a delay of minutes can affect recovery. The BEFAST-Plus table (Balance, Eyes, Face, Arms, Speech, Time, Plus – assess for sudden weakness or numbness) provides a helpful framework for recognizing stroke symptoms.

Stroke in younger adults is increasing, and while traditional vascular risk factors remain key, drugs of abuse are now recognized as significant, preventable causes. Methamphetamine and cocaine use clearly increase stroke risk, while cannabis has a more modest, but increasingly significant, effect. Substance use should be considered an important modifiable risk factor for stroke and myocardial infarction. Prevention and early intervention are crucial to mitigating these risks.

Looking Ahead: The University of Cambridge research team plans to continue investigating the specific mechanisms by which these drugs contribute to stroke, with the goal of developing targeted prevention strategies. Further research is also needed to better understand the long-term effects of cannabis use on cardiovascular health and stroke risk. Public health initiatives aimed at raising awareness of these risks, particularly among young adults, are essential to reducing the incidence of preventable strokes.